Surgery in the multimodality treatment of sinonasal malignancies

Current Problems in Cancer

Volumn 34, Issue 5, 2010, Pages 304-321

  Lango, Miriam N ^a   Topham, Neal S ^a   Perlis, Clifford S ^a   Flieder, Douglas B ^a   Weaver, Michael W ^b   Turaka, Aruna ^a   Patel, Sameer A ^a   Ridge, John A ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; IFOSFAMIDE; MOLECULAR MARKER; PACLITAXEL;

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; DRUG FATALITY; DRUG MEGADOSE; HISTOPATHOLOGY; HUMAN; MULTIPLE CYCLE TREATMENT; PARANASAL SINUS CANCER; POSTOPERATIVE COMPLICATION; SQUAMOUS CELL CARCINOMA; WART VIRUS;

CARCINOMA; CARCINOMA, NEUROENDOCRINE; HUMANS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PARANASAL SINUS NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 77956801699     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2010.07.001     Document Type: Article

References (41)

1. Alos L., Moyano S., Nadal A., et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer 2009, 115(12):2701-2709.
2. Wenig B.M. Undifferentiated malignant neoplasms of the sinonasal tract. Arch Pathol Lab Med 2009, 133(5):699-712.
3. Atlas of Tumor Pathology 1988, Armed Forces Institute of Pathology, Washington, D.C. V.J. Hyams, J.G. Batsakis, L. Michaels (Eds.).
4. Taxy J.B., Bharani N.K., Mills S.E., et al. The spectrum of olfactory neural tumors. A light-microscopic immunohistochemical and ultrastructural analysis. Am J Surg Pathol 1986, 10(10):687-695.
5. Rosenthal D.I., Barker J.L., El-Naggar A.K., et al. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer 2004, 101(11):2567-2573.
6. Kadish S., Goodman M., Wang C.C. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976, 37(3):1571-1576.
7. AJCC Cancer Staging Manual 2010, American Joint Committee on Cancer, Springer, New York. (ed 7).
8. Mendenhall W.M., Amdur R.J., Hinerman R.W., et al. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope 2009, 119(10):1994-1999.
9. Ross A.S., Whalen F.M., Elenitsas R., et al. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg 2009, 35(12):1859-1866.
10. Gil Z., Carlson D.L., Gupta A., et al. Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 2009, 135(2):173-179.
11. Dulguerov P., Allal A.S. Nasal and paranasal sinus carcinoma: how can we continue to make progress?. Curr Opin Otolaryngol Head Neck Surg 2006, 14(2):67-72.
12. Dulguerov P., Jacobsen M.S., Allal A.S., et al. Nasal and paranasal sinus carcinoma: are we making progress?. A series of 220 patients and a systematic review. Cancer 2001, 92(12):3012-3029.
13. Hanna EY, Kupferman M, Webber R, et al. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Presented at the American Head and Neck Society Annual Meeting, Las Vegas, 2010.
14. Resto V.A., Chan A.W., Deschler D.G., et al. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 2008, 30(2):222-229.
15. Chen A.M., Daly M.E., Bucci M.K., et al. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement?. Int J Radiat Oncol Biol Phys 2007, 69(1):141-147.
16. Tanzler E.D., Morris C.G., Orlando C.A., et al. Management of sinonasal undifferentiated carcinoma. Head Neck 2008, 30(5):595-599.
17. Moreno M.A., Skoracki R.J., Hanna E.Y., et al. Microvascular free flap reconstruction versus palatal obturation for maxillectomy defects. Head Neck 2010, 32(7):860-868.
18. Ganly I., Patel S.G., Singh B., et al. Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study. Head Neck 2005, 27(6):445-451.
19. Califano J., Cordeiro P.G., Disa J.J., et al. Anterior cranial base reconstruction using free tissue transfer: changing trends. Head Neck 2003, 25(2):89-96.
20. Gil Z., Patel S.G., Bilsky M., et al. Complications after craniofacial resection for malignant tumors: are complication trends changing?. Otolaryngol Head Neck Surg 2009, 140(2):218-223.
21. Hoppe B.S., Wolden S.L., Zelefsky M.J., et al. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity. Head Neck 2008, 30(7):925-932.
22. Dirix P., Vanstraelen B., Jorissen M., et al. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy. Int J Radiat Oncol Biol Phys 2010, Epub ahead of print.
23. Thorup C., Sebbesen L., Dano H., et al. Carcinoma of the nasal cavity and paranasal sinuses in Denmark 1995-2004. Acta Oncol 2010, 49(3):389-394.
24. Giri S.P., Reddy E.K., Gemer L.S., et al. Management of advanced squamous cell carcinomas of the maxillary sinus. Cancer 1992, 69(3):657-661.
25. Amendola B.E., Eisert D., Hazra T.A., et al. Carcinoma of the maxillary antrum: surgery of radiation therapy?. Int J Radiat Oncol Biol Phys 1981, 7(6):743-746.
26. Lee F., Ogura J.H. Maxillary sinus carcinoma. Laryngoscope 1981, 91(1):133-139.
27. Paulino A.C., Marks J.E., Bricker P., et al. Results of treatment of patients with maxillary sinus carcinoma. Cancer 1998, 83(3):457-465.
28. Mendenhall W.M., Amdur R.J., Morris C.G., et al. Carcinoma of the nasal cavity and paranasal sinuses. Laryngoscope 2009, 119(5):899-906.
29. Jang N.Y., Wu H.G., Park C.I., et al. Definitive radiotherapy with or without chemotherapy for T3-4N0 squamous cell carcinoma of the maxillary sinus and nasal cavity. Jpn J Clin Oncol 2010, 40(6):542-548.
30. Hoppe B.S., Nelson C.J., Gomez D.R., et al. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2008, 72(3):763-769.
31. Lee M.M., Vokes E.E., Rosen A., et al. Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am 1999, 5(4):219-223.
32. Porceddu S., Martin J., Shanker G., et al. Paranasal sinus tumors: Peter MacCallum Cancer Institute experience. Head Neck 2004, 26(4):322-330.
33. Homma A., Oridate N., Suzuki F., et al. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer 2009, 115(20):4705-4714.
34. Kim G.E., Chang S.K., Lee S.W., et al. Neoadjuvant chemotherapy and radiation for inoperable carcinoma of the maxillary antrum: a matched-control study. Am J Clin Oncol 2000, 23(3):301-308.
35. Shibuya H., Horiuchi J., Suzuki S., et al. Maxillary sinus carcinoma: result of radiation therapy. Int J Radiat Oncol Biol Phys 1984, 10(7):1021-1026.
36. Shibuya H., Hoshina M., Shagdarsuren M., et al. Squamous cell carcinoma of the maxillary sinus and the oral part of the upper jaw. Comparison of treatment results. Acta Oncol 1994, 33(1):43-47.
37. Shibuya H., Suzuki S., Horiuchi J., et al. Reappraisal of trimodal combination therapy for maxillary sinus carcinoma. Cancer 1982, 50(12):2790-2794.
38. Shibuya H., Takagi M., Horiuchi J., et al. Clinicopathological study of maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 1985, 11(9):1709-1712.
39. Papadimitrakopoulou V.A., Ginsberg L.E., Garden A.S., et al. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer 2003, 98(10):2214-2223.
40. Rischin D., Porceddu S., Peters L., et al. Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck 2004, 26(5):435-441.
41. Bhandare N., Monroe A.T., Morris C.G., et al. Does altered fractionation influence the risk of radiation-induced optic neuropathy?. Int J Radiat Oncol Biol Phys 2005, 62(4):1070-1077.